Vericel Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)
Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV)
Vericel Analyst Ratings
Buy Rating Affirmed for Vericel on Strong Financials and Growth Prospects
BTIG Keeps Their Buy Rating on Vericel (VCEL)
BTIG Remains a Buy on Vericel (VCEL)
Vericel Upgraded at Truist on Growth Acceleration Potential
Vericel Analyst Ratings
Vericel Analyst Ratings
Leerink Partners Remains a Buy on Vericel (VCEL)
BTIG Reaffirms Their Hold Rating on Vericel (VCEL)
BTIG Sticks to Its Buy Rating for Vericel (VCEL)
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Irhythm Technologies (IRTC) and Meiragtx Holdings (MGTX)
Vericel's Growth Potential and Distinct Product Profiles: The Basis for a Buy Rating
Vericel Stock's Promising Outlook: Buy Rating, Increased Price Target, and High-Growth MedTech Potential
Truist Securities Maintains Hold on Vericel, Raises Price Target to $39
Vericel Analyst Ratings
Hold Rating on Vericel: A Measured Approach on Future Growth Amid Slower NexoBrid Ramp and Valuation Concerns
No Data